nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acetic acid/aluminium acetate
|
|
|
2010 |
1303 |
1 |
p. 7 |
artikel |
2 |
A closer look at natalizumab, PML
|
|
|
2010 |
1303 |
1 |
p. 6 |
artikel |
3 |
Alcohol
|
|
|
2010 |
1303 |
1 |
p. 7 |
artikel |
4 |
Alendronic acid
|
|
|
2010 |
1303 |
1 |
p. 7 |
artikel |
5 |
Amfetamine abuse
|
|
|
2010 |
1303 |
1 |
p. 7-8 |
artikel |
6 |
Amphotericin B
|
|
|
2010 |
1303 |
1 |
p. 8 |
artikel |
7 |
Antibacterial resistance largely due to primary-care prescribing?
|
|
|
2010 |
1303 |
1 |
p. 2 |
artikel |
8 |
Anticoagulants
|
|
|
2010 |
1303 |
1 |
p. 8 |
artikel |
9 |
Antineoplastics
|
|
|
2010 |
1303 |
1 |
p. 8 |
artikel |
10 |
Antithrombotics
|
|
|
2010 |
1303 |
1 |
p. 9 |
artikel |
11 |
Antithymocyte globulin/methylprednisolone
|
|
|
2010 |
1303 |
1 |
p. 9 |
artikel |
12 |
Aripiprazole/tiapride
|
|
|
2010 |
1303 |
1 |
p. 9 |
artikel |
13 |
Arsenic trioxide
|
|
|
2010 |
1303 |
1 |
p. 9 |
artikel |
14 |
Arsenic trioxide/corticosteroids/methotrexate
|
|
|
2010 |
1303 |
1 |
p. 10 |
artikel |
15 |
Asparaginase/pegaspargase
|
|
|
2010 |
1303 |
1 |
p. 10 |
artikel |
16 |
Azathioprine/prednisolone
|
|
|
2010 |
1303 |
1 |
p. 11 |
artikel |
17 |
BCG
|
|
|
2010 |
1303 |
1 |
p. 11 |
artikel |
18 |
BCG
|
|
|
2010 |
1303 |
1 |
p. 11 |
artikel |
19 |
Betamethasone
|
|
|
2010 |
1303 |
1 |
p. 11 |
artikel |
20 |
Bevacizumab
|
|
|
2010 |
1303 |
1 |
p. 11-12 |
artikel |
21 |
Bifonazole
|
|
|
2010 |
1303 |
1 |
p. 12 |
artikel |
22 |
Bupivacaine/fentanyl/pethidine
|
|
|
2010 |
1303 |
1 |
p. 12 |
artikel |
23 |
Carbamazepine
|
|
|
2010 |
1303 |
1 |
p. 13 |
artikel |
24 |
Carbamazepine
|
|
|
2010 |
1303 |
1 |
p. 12 |
artikel |
25 |
Carbamazepine
|
|
|
2010 |
1303 |
1 |
p. 13 |
artikel |
26 |
Carbamazepine/mexiletine
|
|
|
2010 |
1303 |
1 |
p. 13 |
artikel |
27 |
Cetuximab
|
|
|
2010 |
1303 |
1 |
p. 14 |
artikel |
28 |
Ciprofloxacin
|
|
|
2010 |
1303 |
1 |
p. 14 |
artikel |
29 |
Ciprofloxacin
|
|
|
2010 |
1303 |
1 |
p. 14 |
artikel |
30 |
Cisplatin
|
|
|
2010 |
1303 |
1 |
p. 14 |
artikel |
31 |
Citalopram/escitalopram/venlafaxine withdrawal
|
|
|
2010 |
1303 |
1 |
p. 15 |
artikel |
32 |
Clomifene
|
|
|
2010 |
1303 |
1 |
p. 15 |
artikel |
33 |
Clozapine
|
|
|
2010 |
1303 |
1 |
p. 15 |
artikel |
34 |
Cyclophosphamide
|
|
|
2010 |
1303 |
1 |
p. 15 |
artikel |
35 |
Cyclophosphamide/dexamethasone
|
|
|
2010 |
1303 |
1 |
p. 16 |
artikel |
36 |
Cyclophosphamide/type II DNA topoisomerase inhibitors
|
|
|
2010 |
1303 |
1 |
p. 16 |
artikel |
37 |
Cytarabine/fludarabine/mitoxantrone
|
|
|
2010 |
1303 |
1 |
p. 16-17 |
artikel |
38 |
Diltiazem/losartan
|
|
|
2010 |
1303 |
1 |
p. 17 |
artikel |
39 |
Diphtheria tetanus and pertussis vaccine
|
|
|
2010 |
1303 |
1 |
p. 17 |
artikel |
40 |
Docetaxel/prednisone
|
|
|
2010 |
1303 |
1 |
p. 17 |
artikel |
41 |
Droperidol
|
|
|
2010 |
1303 |
1 |
p. 18 |
artikel |
42 |
Epirubicin/tretinoin
|
|
|
2010 |
1303 |
1 |
p. 18 |
artikel |
43 |
Etanercept
|
|
|
2010 |
1303 |
1 |
p. 18 |
artikel |
44 |
Etanercept
|
|
|
2010 |
1303 |
1 |
p. 18 |
artikel |
45 |
FDA Task Force unveils next step in Transparency Initiative
|
|
|
2010 |
1303 |
1 |
p. 6 |
artikel |
46 |
Fentanyl/remifentanil abuse
|
|
|
2010 |
1303 |
1 |
p. 19 |
artikel |
47 |
General anaesthetics/phenylephrine
|
|
|
2010 |
1303 |
1 |
p. 19 |
artikel |
48 |
Haloperidol overdose
|
|
|
2010 |
1303 |
1 |
p. 19 |
artikel |
49 |
Heparin
|
|
|
2010 |
1303 |
1 |
p. 19 |
artikel |
50 |
Heparin
|
|
|
2010 |
1303 |
1 |
p. 20 |
artikel |
51 |
Hepatitis B immune globulin
|
|
|
2010 |
1303 |
1 |
p. 20 |
artikel |
52 |
High-dose vitamin D increases falls and fractures in elderly
|
|
|
2010 |
1303 |
1 |
p. 1 |
artikel |
53 |
Hyaluronidase/levobupivacaine/lidocaine
|
|
|
2010 |
1303 |
1 |
p. 20 |
artikel |
54 |
Imatinib/nilotinib
|
|
|
2010 |
1303 |
1 |
p. 20-21 |
artikel |
55 |
Infliximab
|
|
|
2010 |
1303 |
1 |
p. 21 |
artikel |
56 |
Irbesartan/sitagliptin interaction
|
|
|
2010 |
1303 |
1 |
p. 21 |
artikel |
57 |
Isotretinoin
|
|
|
2010 |
1303 |
1 |
p. 21-22 |
artikel |
58 |
Isotretinoin
|
|
|
2010 |
1303 |
1 |
p. 22 |
artikel |
59 |
Ketamine abuse
|
|
|
2010 |
1303 |
1 |
p. 22 |
artikel |
60 |
Lamivudine/stavudine/nevirapine
|
|
|
2010 |
1303 |
1 |
p. 22 |
artikel |
61 |
Lamivudine/zidovudine
|
|
|
2010 |
1303 |
1 |
p. 22 |
artikel |
62 |
Leuprorelin
|
|
|
2010 |
1303 |
1 |
p. 23 |
artikel |
63 |
Lithium
|
|
|
2010 |
1303 |
1 |
p. 23 |
artikel |
64 |
Lithium
|
|
|
2010 |
1303 |
1 |
p. 23 |
artikel |
65 |
Lithium
|
|
|
2010 |
1303 |
1 |
p. 23 |
artikel |
66 |
Mefenamic acid
|
|
|
2010 |
1303 |
1 |
p. 23 |
artikel |
67 |
Melphalan
|
|
|
2010 |
1303 |
1 |
p. 24 |
artikel |
68 |
Metformin associated with progressive vitamin B12 deficiency
|
|
|
2010 |
1303 |
1 |
p. 5 |
artikel |
69 |
Methadone
|
|
|
2010 |
1303 |
1 |
p. 24 |
artikel |
70 |
Methadone withdrawal
|
|
|
2010 |
1303 |
1 |
p. 24 |
artikel |
71 |
Methylphenidate
|
|
|
2010 |
1303 |
1 |
p. 25 |
artikel |
72 |
Methylphenidate/pseudoephedrine interaction
|
|
|
2010 |
1303 |
1 |
p. 25 |
artikel |
73 |
Methylprednisolone
|
|
|
2010 |
1303 |
1 |
p. 25 |
artikel |
74 |
Mirtazapine
|
|
|
2010 |
1303 |
1 |
p. 25 |
artikel |
75 |
Mitoxantrone
|
|
|
2010 |
1303 |
1 |
p. 26 |
artikel |
76 |
Mivacurium chloride
|
|
|
2010 |
1303 |
1 |
p. 26 |
artikel |
77 |
Momordica charantia
|
|
|
2010 |
1303 |
1 |
p. 26 |
artikel |
78 |
News from DDW
|
|
|
2010 |
1303 |
1 |
p. 4-5 |
artikel |
79 |
News from PAS
|
|
|
2010 |
1303 |
1 |
p. 3 |
artikel |
80 |
Oxaliplatin
|
|
|
2010 |
1303 |
1 |
p. 26 |
artikel |
81 |
Oxybutynin
|
|
|
2010 |
1303 |
1 |
p. 27 |
artikel |
82 |
Paclitaxel
|
|
|
2010 |
1303 |
1 |
p. 27 |
artikel |
83 |
Pamidronic acid/zoledronic acid
|
|
|
2010 |
1303 |
1 |
p. 27 |
artikel |
84 |
Pantoprazole
|
|
|
2010 |
1303 |
1 |
p. 27 |
artikel |
85 |
Paracetamol overdose
|
|
|
2010 |
1303 |
1 |
p. 28 |
artikel |
86 |
Peginterferon α
|
|
|
2010 |
1303 |
1 |
p. 28 |
artikel |
87 |
Peginterferon
|
|
|
2010 |
1303 |
1 |
p. 28 |
artikel |
88 |
Perfluorocarbon
|
|
|
2010 |
1303 |
1 |
p. 29 |
artikel |
89 |
Phenytoin
|
|
|
2010 |
1303 |
1 |
p. 29 |
artikel |
90 |
Pimecrolimus
|
|
|
2010 |
1303 |
1 |
p. 29 |
artikel |
91 |
Pneumococcal vaccine programme requires reevaluation
|
|
|
2010 |
1303 |
1 |
p. 3 |
artikel |
92 |
Politef
|
|
|
2010 |
1303 |
1 |
p. 29 |
artikel |
93 |
Prednisolone
|
|
|
2010 |
1303 |
1 |
p. 30 |
artikel |
94 |
Prednisolone
|
|
|
2010 |
1303 |
1 |
p. 30 |
artikel |
95 |
Propofol
|
|
|
2010 |
1303 |
1 |
p. 30 |
artikel |
96 |
Rituximab
|
|
|
2010 |
1303 |
1 |
p. 31 |
artikel |
97 |
Rituximab
|
|
|
2010 |
1303 |
1 |
p. 30 |
artikel |
98 |
Serenoa repens
|
|
|
2010 |
1303 |
1 |
p. 31 |
artikel |
99 |
Sertraline/venlafaxine
|
|
|
2010 |
1303 |
1 |
p. 31 |
artikel |
100 |
Sildenafil
|
|
|
2010 |
1303 |
1 |
p. 31 |
artikel |
101 |
Sorafenib
|
|
|
2010 |
1303 |
1 |
p. 32 |
artikel |
102 |
Spironolactone prescribing ‘safe’ in UK NHS setting
|
|
|
2010 |
1303 |
1 |
p. 6 |
artikel |
103 |
Statins: quantifiable benefits outweigh risks in real world
|
|
|
2010 |
1303 |
1 |
p. 2 |
artikel |
104 |
Sunitinib
|
|
|
2010 |
1303 |
1 |
p. 32 |
artikel |
105 |
Valproate
|
|
|
2010 |
1303 |
1 |
p. 32-33 |
artikel |
106 |
Valproic acid
|
|
|
2010 |
1303 |
1 |
p. 33 |
artikel |
107 |
Valproic acid
|
|
|
2010 |
1303 |
1 |
p. 33 |
artikel |
108 |
Vancomycin
|
|
|
2010 |
1303 |
1 |
p. 34 |
artikel |
109 |
Vitamin K antagonist recipients do not require especially close monitoring of INR values following influenza vaccination
|
|
|
2010 |
1303 |
1 |
p. 5 |
artikel |
110 |
Warfarin overdose
|
|
|
2010 |
1303 |
1 |
p. 34 |
artikel |
111 |
Zoledronic acid
|
|
|
2010 |
1303 |
1 |
p. 34 |
artikel |
112 |
Zoledronic acid
|
|
|
2010 |
1303 |
1 |
p. 35 |
artikel |